Lead Product(s) : Np339
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : NP339 as a novel peptide therapy candidate for invasive and respiratory fungal disease. NP339 has rapid, fungicidal activity against a broad range of clinically relevant pathogens.
Product Name : Undisclosed
Product Type : Peptide, Unconjugated
Upfront Cash : Inapplicable
October 05, 2021
Lead Product(s) : Np339
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
